| A147T TSPO | Ala147Thr translocator protein |
| AD | Alzheimer’s disease |
| ALS | amyotrophic lateral sclerosis |
| BBB | blood-brain barrier |
| BPND | binding potential |
| CNS | central nervous system |
| DAMPs | danger-associated molecular patterns |
| FTD | frontotemporal dementia |
| GFAP | glial fibrillary acidic protein |
| GWAS | genome-wide association studies |
| HAB | high affinity binder |
| HLA | human leukocyte antigen |
| IFNγ | interferon-γ |
| IL | interleukin |
| Ki | affinity |
| LAB | low affinity binder |
| LPS | lipopolysaccharide |
| MAB | mixed affinity binder |
| PAMPs | pathogen-associated molecular patterns |
| PET | positron emission tomography |
| MAB | mixed affinity binder |
| PAMPs | pathogen-associated molecular patterns |
| PD | Parkinson’s disease |
| PET | positron emission tomography |
| PRRs | pattern recognition receptors |
| RsTSPO | Rhodobacter sphaeroides translocator protein |
| SNP | single nucleotide polymorphism |
| TLRs | toll-like receptors |
| TSPO | translocator protein |
| WT TSPO | wild type translocator protein |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.